"We are proud to announce that the HLA Institute has pioneered a monitoring solution for xenotransplant recipients. By integrating single-cell sequencing​ with sophisticated data analysis, we can now precisely monitor the trajectory of post-transplant antibody responses in real-time. This technology provides a critical window for early intervention against rejection, ensuring better outcomes for patients receiving animal-derived organs."